These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 21627510)
1. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs. Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187 [TBL] [Abstract][Full Text] [Related]
3. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. Stanclift RM; Gilson SD J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109 [TBL] [Abstract][Full Text] [Related]
6. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. Weisse C; Shofer FS; Sorenmo K J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012). Pratschke KM; Atherton MJ; Sillito JA; Lamm CG J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Abadie JJ; Amardeilh MA; Delverdier ME J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425 [TBL] [Abstract][Full Text] [Related]
10. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031 [TBL] [Abstract][Full Text] [Related]
11. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008). Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363 [TBL] [Abstract][Full Text] [Related]
14. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors. Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs. Selmic LE; Ruple A BMC Vet Res; 2020 Jan; 16(1):5. PubMed ID: 31906934 [TBL] [Abstract][Full Text] [Related]
16. Nucleomorphometric analysis of canine cutaneous mast cell tumours. Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229 [TBL] [Abstract][Full Text] [Related]
18. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010-2013). Risselada M; Mathews KG; Griffith E J Am Vet Med Assoc; 2015 Jul; 247(2):184-9. PubMed ID: 26133218 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554 [TBL] [Abstract][Full Text] [Related]
20. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001). Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]